Vimarsana
Biggest News Aggregation in the World

Page 16 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

DCGI Collating Data of Pharma Plants - Vimarsana News

DCGI Collating Data of Pharma Plants

After a major drive by the government against spurious and substandard drugs, Indias drug regulator has started collating and compiling the profiles of pharmaceutical plants in the country.The Drug Controller General of India (DCGI) has asked drug companies to provide details of each of their units operational in the country.

Morning Scan: All the big stories to get you started for the day - Vimarsana News

Morning Scan: All the big stories to get you started for the day

A round-up of the biggest articles from newspapers

dcgi: After crackdown on spurious medicines, India's drug regulator collating data of pharma plants - Vimarsana News

dcgi: After crackdown on spurious medicines, India's drug regulator collating data of pharma plants

The companies have also been asked to share information on international approvals obtained from the European Union, US Food and Drug Administration, Japan's Pharmaceuticals and Medical Devices Agency, Brazilian Health Regulatory Agency (Anvisa), among other regulatory bodies abroad.

Over 50% Indian families faced unknown side effects from medicines: Survey - Vimarsana News

Over 50% Indian families faced unknown side effects from medicines: Survey

85% Indians want it to be mandatory for manufacturers to display main side effects on the packaging or via a leaflet, says a LocalCircles survey

digene: Digene users, take note! Health regulator has issued an important advisory for you - Vimarsana News

digene: Digene users, take note! Health regulator has issued an important advisory for you

The Drug Controller General of India has issued a cautionary advisory to doctors and healthcare professionals regarding the discontinuation of Digene gel in the event of adverse drug reactions. This follows a complaint received by the DCGI about a batch of Digene gel produced by Abbott India in Goa, which had unusual characteristics.